Cotellic 20 MG tablet 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FGBR1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,899
Award facts
- Contract value 100% obligated
- $5,899.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,899.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cotellic 20 mg tablets (63-count). The award, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, represents a firm fixed-price delivery order with no set-aside designation. This contract is executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to support Department of Defense pharmaceutical supply requirements globally.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. As a critical pharmaceutical supplier within the federal military medical system, DMS Pharmaceutical Group maintains an extensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's demonstrated performance on numerous delivery orders and its established presence in the federal pharmaceutical supply chain since 2001 position it to fulfill the diverse medical supply needs of Department of Defense healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FGBR1?
SPE2DR26FGBR1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FGBR1 worth?
The government has obligated $5,899 on SPE2DR26FGBR1.
Is contract SPE2DR26FGBR1 an order under another contract?
Yes. SPE2DR26FGBR1 is a delivery order under SPE2DR25D9315, an indefinite delivery contract.
Was contract SPE2DR26FGBR1 competed?
The extent of competition for SPE2DR26FGBR1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award